Compound class:
Peptide
Comment: GE-137 is a cyclic peptide constructed as a fluorescent probe for the detection of colorectal polyps by binding to human tyrosine kinase c-Met [1-2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Burggraaf J, Kamerling IM, Gordon PB, Schrier L, de Kam ML, Kales AJ, Bendiksen R, Indrevoll B, Bjerke RM, Moestue SA et al.. (2015)
Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met. Nat Med, 21 (8): 955-61. [PMID:26168295] |
2. Nairne RJD, Healey AJ, Johannesen EW. (2013)
Peptide imaging agents. Patent number: US8431111 B2. Assignee: GE Healthcare Limited.. Priority date: 31/07/2007. Publication date: 30/04/2013. |